THE EVALUATION OF ACTN3 R577X POLYMORPHISM IN ELITE MALE TURKISH ATHLETES

Year 2025, Volume: 19 Issue: 3, 330 - 340, 30.12.2025

Melahat Kurtuluş , Kadir Keskin , Mehmet Gunay

https://doi.org/10.61962/bsd.1799101

Abstract

Athletic performance is a complex genetic trait influenced by environmental interaction and genetic make-up. The α actinin-3 protein encoded by the ACTN3 gene might be associated with athletic status. The aims of this study were to evaluate the differences in the genotype distribution of the ACTN3 R577X polymorphism in elite Turkish wrestlers, football players, and endurance runners and to investigate whether this polymorphism is associated power/strength (wrestling and football) and endurance-based athletes (endurance running) with athletic performance. 53 wrestlers, 71 football players, 34 endurance runners, including 56 controls were participated to this study. Genotyping of ACTN3 R577X polymorphism was performed by polymerase chain reaction-restriction fragment length polymorphism method. The ACTN3 genotype frequencies of athletes were 37.7% RR, 52.8% RX, and 9.4% XX for wrestling, 43.7% RR, 40.8% XX, and 15.5% XX for fooball players, and 32.4% RR, 47.1% RX, and 20.6% XX for endurance running. To establish the differences in the genotype distribution and allelic frequency of the ACTN3 R577X were compared elite Turkish athletes with controls, and power/strength with endurance-based athletes. No significant difference was observed among athlete cohorts (p>0.05). Our findings verified that although there are many diverse over metabolic and mechanical determinants, the ACTN3 gene is similar over distinct types of sports disciplines, such as wrestling, endurance running and soccer.

Keywords

ACTN3 R577X , Elite athletes , Turkish population , genes

Ethical Statement

The study were approved by Gazi of University Clinical Research Ethical Committee with the number of 217 and the date 23/05/2012.

Supporting Institution

This study has been supported by Gazi UniversityScientific Research Projects Coordination Unit under grant number 02/2010-33.

Thanks

The authors thank to Kadir Gökdemir for presenting the project and collecting samples.

ELİT ERKEK TÜRK SPORCULARINDA ACTN3 R577X POLİMORFİZMİNİN DEĞERLENDİRİLMESİ

Abstract

Atletik performans, çevresel etkileşim ve genetik yapıdan etkilenen karmaşık bir genetik özelliktir. ACTN3 geni tarafından kodlanan α aktin-3 proteini, atletik statü ile ilişkili olabilir. Bu çalışmanın amaçları, elit Türk güreşçileri, futbolcuları ve dayanıklılık koşucularında ACTN3 R577X polimorfizminin genotip ağılımındaki farklılıkları değerlendirmek ve bu polimorfizmin güç/kuvvet (güreş ve futbol) ve dayanıklılık odaklı sporcularda (dayanıklılık koşusu) atletik performansla ilişkili olup olmadığını raştırmaktır. Çalışmaya 53 güreşçi, 71 futbolcu ve 56 kontrol olmak üzere 34 dayanıklılık koşucusu katılmıştır. ACTN3 R577X polimorfizminin genotiplendirilmesi, polimeraz zincir reaksiyonu-restriksiyon fragman uzunluk polimorfizmi yöntemi ile gerçekleştirilmiştir. Sporcuların ACTN3 genotip frekansları güreş için %37,7 RR, %52,8 RX ve %9,4 XX; futbol oyuncuları için %43,7 RR, %40,8 XX ve %15,5 XX; dayanıklılık koşusu için ise %32,4 RR, %47,1 RX ve %20,6 XX olarak bulunmuştur. ACTN3 577X geninin genotip dağılımı ve alelik frekansındaki farklılıkları belirlemek için elit Türk sporcular kontrollerle, güç/kuvvet ise dayanıklılık temelli sporcularla karşılaştırılmıştır. Sporcu grupları arasında anlamlı bir fark gözlenmemiştir (p>0,05). Bulgularımız, birçok farklı metabolik ve mekanik belirleyici olmasına rağmen, ACTN3 geninin güreş, dayanıklılık koşusu ve futbol gibi farklı spor disiplinlerinde benzer olduğunu doğrulamıştır.

Keywords

ACTN3 R577X , elit sporcu , türk popülasyonu , gen

Ethical Statement

Çalışma Gazi Üniversitesi Klinik Araştırmalar Etik Kurulu’nun 23/05/2012 tarih ve 217 sayılı kararıyla onaylandı.

Supporting Institution

Bu çalışma Gazi Üniversitesi Bilimsel Araştırma Projeleri Koordinasyon Birimi tarafından 02/2010-33 hibe numarasıyla desteklenmiştir.

Thanks

Yazarlar, projeyi sunma ve örnek toplama konusunda emeği geçen Kadir Gökdemir'e teşekkürlerini sunarlar.

References

• 1. Bouchard C (2011). Overcoming barriers to progress in exercise genomics. Exercise and Sport Sciences Reviews. 39(4), 212–217.
• 2. Miyamoto-Mikami E, Zempo H, Fuku N, Kikuchi N, Miyachi M, Murakami H (2018). Heritability estimates of endurance-related phenotypes: A systematic review and meta-analysis. Scandinavian Journal of Medicine and Science in Sports. 28, 834–845.
• 3. Zempo H, Miyamoto-Mikami E, Kikuchi N, Fuku N, Miyachi M, Murakami H (2016). Heritability estimates of muscle strength-related phenotypes: A systematic review and meta-analysis. Scandinavian Journal of Medicine and Science in Sports. 26, 1–10.
• 4. Pickering C, Kiely J, Grgic J, Lucia A, Del Coso J (2019). Can genetic testing identify talent for sport? Genes (Basel). 10, 972.
• 5. Ahmetov II, Druzhevskaya AM, Lyubaeva EV, Popov DV, Vinogradova OL, Williams AG (2011). The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Experimental Physiology. 96(12), 1302–1310.
• 6. Baker LB, Rollo I, Stein KW, Jeukendrup AE (2015). Acute effects of carbohydrate supplementation on intermittent sports performance. Nutrients. 7, 5733–5763.
• 7. Bangsbo J, Mohr M, Krustrup P (2006). Physical and metabolic demands of training and match-play in the elite football player. Journal of Sports Sciences. 24(7), 665–674.
• 8. Ribas MR, Netto ZCO, Salgueirosa F, Fernandes P, Matos O, Bassan JC (2017). Association of ACTN3 R577X and ACE I/D polymorphisms in Brazilian wrestlers. Revista Brasileira de Medicina do Esporte. 23(6), 469–472.
• 9. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, et al (2001). Differential expression of the actin-binding proteins α-actinin-2 and -3 in different species. Human Molecular Genetics. 10(13), 1335–1346.
• 10. MacArthur DG, North KN (2007). ACTN3: A genetic influence on muscle function and athletic performance. Exercise and Sport Sciences Reviews. 35, 30–34.
• 11. MacArthur DG, North KN (2004). A gene for speed? The evolution and function of alpha-actinin-3. BioEssays. 26, 786–795.
• 12. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, Beggs AH (1999). A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nature Genetics. 21, 353–354.
• 13. Houweling PJ, Berman YD, Turner N, Quinlan KGR, Seto JT, Yang N, et al (2017). Exploring the relationship between α-actinin-3 deficiency and obesity. International Journal of Obesity. 41, 1154–1157.
• 14. MacArthur DG, Seto JT, Chan S, Quinlan KGR, Raftery JM, Turner N, et al (2008). An ACTN3 knockout mouse provides mechanistic insights. Human Molecular Genetics. 17(8), 1076–1086.
• 15. MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, Hook JW, et al (2007). Loss of ACTN3 gene function alters mouse muscle metabolism. Nature Genetics. 39(10), 1261–1265.
• 16. McAuley ABT, Hughes DC, Tsaprouni LG, Varley I, Suraci B, Roos TR, Herbert AJ, Kelly AL (2021). ACTN3 and ACE polymorphisms with athlete status in football. Journal of Sports Sciences. 39(2), 200–211.
• 17. Coelho DB, Pimenta EM, Rosse IC, de Castro BM, Becker LK, de Oliveira EC, et al (2018). ACTN3 polymorphism in football players’ career progression. International Journal of Sports Medicine. 39(14), 1088–1093.
• 18. Eynon N, Banting LK, Ruiz JR, Cieszczyk P, Dyatlov DA, Maciejewska-Karlowska A, et al (2014). ACTN3 polymorphism and team-sport performance. Journal of Science and Medicine in Sport. 17(1), 102–106.
• 19. Druzhevskaya AM, Ahmetov II, Astratenkova IV, Rogozkin VA (2008). ACTN3 polymorphism with power athlete status. European Journal of Applied Physiology. 103, 631–634.
• 20. Abián-Vicén J, Abián P, Bravo-Sánchez A, Piñas-Bonilla I, Lara B, Del Coso J (2022). ACTN3 polymorphism in elite badminton players. Genes. 14(1), 50.
• 21. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, et al (2003). ACTN3 genotype and elite athletic performance. American Journal of Human Genetics. 73, 627–631.
• 22. Roth SM, Walsh S, Liu D, Metter EJ, Ferrucci L, Hurley BF (2008). ACTN3 nonsense allele in elite strength athletes. European Journal of Human Genetics. 16, 391–394.
• 23. Lucia A, Olivan J, Gomez-Gallego F, Santiago C, Montil M, Foster C (2007). Faster and longer with no α-actinin-3? British Journal of Sports Medicine. 41, 616–617.
• 24. Ahmetov II, Druzhevskaya AM, Astratenkova IV, Popov DV, Vinogradova OL, Rogozkin VA (2010). ACTN3 polymorphism in endurance athletes. British Journal of Sports Medicine. 44(9), 649–652.
• 25. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P, et al (2007). ACTN3 genotype and fiber type distribution. Physiological Genomics. 32, 58–63.
• 26. Niemi AK, Majamaa K (2005). Mitochondrial DNA and ACTN3 genotypes. European Journal of Human Genetics. 13(8), 965–969.
• 27. Del Coso J, Rodas G, Buil MA, Sánchez-Sánchez J, López P, González-Ródenas J, et al (2022). ACTN3 polymorphism in professional women football players. Genes. 13(9), 1635.
• 28. Ulucan K (2016). ACTN3 R577X polymorphism in Turkish sportsmen. Clinical and Experimental Health Sciences. 6(1), 44–47.
• 29. Kurtuluş M, Keskin K, Gunay M, Kesici T, Gökdemir K (2023). Genetic differences in PPARα gene in athletes. Journal of Basic and Clinical Health Sciences. 7, 723–730.
• 30. Sambrook J, Fritsch EF, Maniatis T (1989). Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press.
• 31. Ortiz M, Ayala A, Petro JL, Argothy R, Garzon J, Bonilla DA (2022). ACTN3 and ACE polymorphisms in young athletes. Journal of Human Sport and Exercise. 17(3), 626–639.
• 32. Clos E, Pruna R, Lundblad M, Artells R, Maffulli N (2021). ACTN3 allele distribution by playing position. Medical Principles and Practice. 30, 92–97.
• 33. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, et al (2006). ACTN3 genotype in endurance cyclists. International Journal of Sports Medicine. 27(11), 880–884.
• 34. Eynon N, Duarte JA, Oliveira J, Sagiv M, Yamin C, Meckel Y, et al (2009). ACTN3 polymorphism in Israeli elite athletes. International Journal of Sports Medicine. 30, 695–698.
• 35. Saunders CJ, September AV, Xenophontos SL, Cariolou MA, Anastassiades LC, Noakes TD, et al (2007). ACTN3 polymorphism in Ironman triathletes. Annals of Human Genetics. 71, 777–781.
• 36. Muniesa CA, Gonzalez-Freire M, Santiago C, Lao JI, Buxens A, Rubio JC, et al (2010). Genetic influence on rowing performance. British Journal of Sports Medicine. 44(12), 898–901.
• 37. Döring FE, Onur S, Geisen U, Boulay MR, Perusse L, Rankinen T, et al (2010). ACTN3 polymorphisms and elite endurance athlete status. Journal of Sports Sciences. 28(12), 1355–1359.
• 38. Eynon N, Ruiz JR, Femia P, Pushkarev VP, Cieszczyk P, Maciejewska-Karlowska A, et al (2012). ACTN3 polymorphism across European athletes. PLoS ONE. 7(8), e43132.
• 39. Yang N, Garton F, North K (2009). α-Actinin-3 and performance. In Collins M (Ed.), Genetics and sports. Med Sport Sci, 54, 88–101.
• 40. Baltazar-Martins G, Gutiérrez-Hellín J, Aguilar-Navarro M, Ruiz-Moreno C, Moreno-Pérez V, López-Samanes A, et al (2020). ACTN3 genotype, muscle damage and injury. Sports. 8, 99.
• 41. Egorova ES, Borisova AV, Mustafina LJ, Arkhipova AA, Rashid T, Gabbasov RT, et al (2014). Polygenic profile of Russian football players. Journal of Sports Sciences. 32(13), 1286–1293.
• 42. Pimenta EM, Coelho DB, Veneroso CE, Coelho EJB, Cruz IR, Morandi RF (2013). Effect of ACTN3 gene on strength and endurance in soccer players. Journal of Strength and Conditioning Research. 27, 3286–3292.
• 43. Santiago C, Gonzalez-Freire M, Serratosa L, Morate FJ, Meyer T, Gomez-Gallego F (2008). ACTN3 genotype in professional soccer players. British Journal of Sports Medicine. 42, 71–73.
• 44. Kikuchi N, Min SK, Ueda D, Igawa S, Nakazato K (2012). ACTN3 and ACE genotypes in elite wrestlers. Journal of Strength and Conditioning Research. 26(12), 3275–3280.